TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Huseyin Ayguen
Chief Scientific Officer at BioSpring

Profile

In 1997 Dr. Hüseyin Aygün co-founded BioSpring GmbH, a world leading oligonucleotide manufacturing company, taking on the role of Chief Scientific Officer (CSO).Since 2006 he has also been responsible for the GMP production and bioconjugation of therapeutic oligonucleotides.

Dr. Aygün obtained his PhD in Chemistry from the University of Frankfurt in 2001.

He is co-inventor of several patents as well as co-author of several publications. 

Huseyin Ayguen's Network

Agenda Sessions

  • Characterization of Raw Materials for the Manufacturing of Oligonucleotides

    , 14:00